Seroprevalence of known and putative hepatitis markers inUnited States blood donors with ALT levels at least 120 IU per L
暂无分享,去创建一个
A. Williams | A. Grindon | R. Cable | R. Dodd | E. Notari | S. Orton | B. Lenes | J. Trouern‐Trend | Yiling Xu | Kimberly M. McMillan | Jennifer S. Wolf‐Nugent
[1] L. Smith,et al. Transfusion–Transmitted Viruses , 2003, American Society for Clinical Laboratory Science.
[2] J. Kiss,et al. Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion Recipients , 1998, Vox Sanguinis.
[3] A. Widell,et al. Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels , 1998, Transfusion.
[4] E. Seifried,et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients , 1997, Transfusion.
[5] R. Cable,et al. Limited utility of alanine aminotransferase screening of hepatitis C antibody‐screened blood donors , 1997, Transfusion.
[6] K. Stark,et al. Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.
[7] H. Margolis,et al. Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.
[8] S. Kleinman,et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study , 1995, Transfusion.
[9] W. H. Hall,et al. Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. , 1995, JAMA.
[10] W. H. Hall,et al. Infectious disease testing for blood transfusions. , 1995, NIH consensus statement.
[11] G. Vyas,et al. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase , 1994, Transfusion.
[12] P. Wutzler,et al. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. , 1993, Journal of virological methods.
[13] L. Mimms,et al. Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays , 1991, Journal of medical virology.
[14] M. Williams,et al. Prevention of transfusion-associated cytomegalovirus (CMV) infection in neonates by screening blood donors for IgM to CMV. , 1988, The Journal of infectious diseases.
[15] G. Vyas,et al. Viral hepatitis : a contemporary assessment of etiology, epidemiology, pathogenesis, and prevention : proceedings of the Second Symposium on Viral Hepatitis, University of California, San Francisco, March 16-19, 1978 , 1978 .